GlaxoSmithKline Third Quarter 2014 Results Interview with CEO Sir Andrew Witty & CFO Simon Dingemans.

Interview with Sir Andrew Witty, CEO, and Simon Dingemans, CFO announcing the company’s Q3 2014 results including a restructuring of the business and a possible partial IPO of ViiV Healthcare.